Business Description
AccuStem Sciences Inc. is a New York-based company founded in 2013 that develops genetic tests to help doctors make better decisions in cancer care. Its two main products are a test that determines whether lung nodules found during screening are cancerous and a separate test that predicts the likelihood of breast cancer returning in certain patients.
